Apogee Therapeutics (NASDAQ:APGE) Trading Down 4 8% etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
SAN FRANCISCO and WALTHAM, Mass., Sept. 14, 2023 Apogee Therapeutics, Inc. , a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis ,.
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) shares were down 4.6% during trading on Thursday . The company traded as low as $20.66 and last traded at $20.67. Approximately 64,569 shares changed hands during trading, a decline of 68% from the average daily volume of 202,654 shares. The stock had previously closed at $21.67. […]